We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Shares of Merck & Co. Inc. fell more than 0.5% on Monday afternoon, tracking their fifth consecutive decline in the worst ...
Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.